Kickit2me and Hercepin,Worth watching when the link goes up....

Kickit2me and Hercepin,

Worth watching when the link goes up. Another comprehensive update from CC following on from the MST interview, and covering the quarterly.

Without going too much into the nuts and bolts:

- Not seeing any pullback in MedTech markets. CDX Health tech markets continue to position strongly with high-growth TAM across all sectors.

- Near term 22 Goals:

FDA Clearance for Pulse
Lodge FDA for CONNEQT Band
Complete CONNEQT Portal and App and Clinician Portal - the clinician portal 'is about to go in ahead of schedule.'
Launch E-Commerce site for Consumer and Clinician Markets
Execute major clinical/consumer partnerships

- He quoted the European Working Group on Hypertension in the Hypertension Journal 2022:

- 'Due to validation procedures and accuracy we cannot recommend any existing wearable for use as a clinical product.'

- Then went on to say that the two authors of this report - I didn't get the names but have asked again - recently joined our Advisory Board 'to help guide us through the process.' Which obviously is quite a big deal.

- The US$6.3M clinical trial revenue is either in contract process now or at contract - it is not a pie-in-the-sky figure pulled out of a hat

- When CC/NC took over Atcor it was nearly bankrupt. It's taken three years to pivot the company to the new strategy. CDX will absolutely be a different company in the next 12 months. Stay the course.

- US listing will be some form of ADR. Pricing not yet finalised. Trying to time this around FDA Clearances and Product launches for maximum impact reaching the US investment base..

- There was a question around FitBit/Garmin/Apple etc. Craig confirmed what he has said previously - they have had multiple discussions with the likes of Apple/Google re their algorithms. He even mentioned Facebook Health. They look at everything that comes across the table. As yet nothing has come of it. When CONNEQT launches they will be the only medical grade wearable and home us device in the market.

- There was a lot on how clinician revenues will be structured around CPT reimbursement codes. CONNEQT will be the only CBPM devices with CPT reimbursement codes. I'll leave that for when the link goes up...

- Finally Funding: All their bankers and regulatory consultants are saying, keep pushing forward. There will be an announcement on funding strategy. It will take a decent chunk of money to do everything. They are very confident that they will have all the capital they need through to launch of Pulse/CONNEQT Band.

- Their focus is clearly and rigorously on Growth and Opportunity.